Marcel Behr appointed interim director McGill Interdisciplinary Initiative in Infection and Immunity
Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency...
Unraveling the complexity of vitamin B12 diseases
Nature Communications study has implications for treatment of patients and genetic counselling
RI-MUHC researchers led one of Québec Science magazine’s top 10 discoveries of the year
Jean-Jacques Lebrun and his team have discovered a promising treatment for triple negative breast cancer
Three RI-MUHC research projects funded in special CIHR calls
Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence
$2M to the MUHC Foundation for precision cancer care
BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program
McGill team’s index predicts coma recovery with 100% accuracy
New Adaptive Reconfiguration Index has crucial implications for clinical management and decision-making in unconscious and unresponsive...
FANCI: a new gene at the origin of some cases of ovarian cancer
For the first time, researchers link mutations in the FANCI gene to the risk of developing ovarian cancer
RI-MUHC trainee Prisca Bustamante honoured by Mitacs Award for Outstanding Innovation
Doctoral student develops world's first non-invasive blood screening test for uveal melanoma
Adel Schwertani is corecipient of the sixth Tomoh Masaki Award
RI-MUHC scientist receives international acclaim for research that benefits pulmonary arterial hypertension patients
RI-MUHC study shows impact of combinatorial immunotherapy on an aggressive cancer
A combinatorial immunotherapy may provide significant therapeutic benefit in managing pancreatic ductal...